Medicines for Europe announces new President, launches Access to Medicines campaign

10 October 2017

The newly elected President of Medicines for Europe – Marc-Alexander Mahl – […]

Medicines for Europe to join the ISPOR Issue Panel on value added medicines

5 October 2017

Value added medicines represent a major opportunity to improve patients’ […]

Medicines for Europe llama a poner en marcha políticas para evitar desabastecimientos

29 September 2017

Addressing medicine shortages in Europe: Competition is crucial for patient access

29 September 2017

Generic medicines have proven to be pivotal in increasing patient […]

Europe needs change to drive added value

15 September 2017

European report calms common concerns

15 September 2017

2017 Biosimilar Medicines Policy Overview: better access is crucial; tailored solutions essential for EU governments

12 September 2017

Biosimilar medicines are transforming treatment by enabling better access to […]

Oncology, the new era for biosimilar medicines

8 September 2017

With more than 10 years of positive experience and 700 […]

Value Added Medicines: Time to adjust the HTA Decision Frameworks for more patient-centric innovation

5 September 2017

A new study “Value Added Medicines: Time to Adjust the […]

País pode poupar “mais 100 milhões por ano” com genéricos

18 July 2017